Lipid droplet binding thalidomide analogs activate endoplasmic reticulum stress and suppress hepatocellular carcinoma in a chemically induced transgenic mouse model

التفاصيل البيبلوغرافية
العنوان: Lipid droplet binding thalidomide analogs activate endoplasmic reticulum stress and suppress hepatocellular carcinoma in a chemically induced transgenic mouse model
المؤلفون: Nagy, Lajos I, Molnár, Eszter, Kanizsai, Iván, Madácsi, Ramóna, Ózsvári, Béla, Fehér, Liliána Z, Fábián, Gabriella, Marton, Annamária, Vizler, Csaba, Ayaydin, Ferhan, Kitajka, Klára, Hackler, László, Mátés, Lajos, Deák, Ferenc, Kiss, Ibolya, Puskás, László G
بيانات النشر: BioMed Central Ltd.
سنة النشر: 2013
المجموعة: BioMed Central
مصطلحات موضوعية: Hepatocellular carcinoma, Lipid droplet, Heat-shock proteins, Protein disulfide isomerase, Reactive oxigen species
الوصف: Background Hepatocellular carcinoma (HCC) is the most frequent and aggressive primary tumor of the liver and it has limited treatment options. Results In this study, we report the in vitro and in vivo effects of two novel amino-trifluoro-phtalimide analogs, Ac-915 and Ac-2010. Both compounds bind lipid droplets and endoplasmic reticulum membrane, and interact with several proteins with chaperone functions (HSP60, HSP70, HSP90, and protein disulfide isomerase) as determined by affinity chromatography and resonant waveguide optical biosensor technology. Both compounds inhibited protein disulfide isomerase activity and induced cell death of different HCC cells at sub or low micromolar ranges detected by classical biochemical end-point assay as well as with real-time label-free measurements. Besides cell proliferation inhibiton, analogs also inhibited cell migration even at 250 nM. Relative biodistribution of the analogs was analysed in native tissue sections of different organs after administration of drugs, and by using fluorescent confocal microscopy based on the inherent blue fluorescence of the compounds. The analogs mainly accumulated in the liver. The effects of Ac-915 and Ac-2010 were also demonstrated on the advanced stages of hepatocarcinogenesis in a transgenic mouse model of N-nitrosodiethylamine (DEN)-induced HCC. Significantly less tumor development was found in the livers of the Ac-915- or Ac-2010-treated groups compared with control mice, characterized by less liver tumor incidence, fewer tumors and smaller tumor size. Conclusion These results imply that these amino-trifluoro-phthalimide analogs could serve potent clinical candidates against HCC alone or in combination with dietary polyunsaturated fatty acids.
نوع الوثيقة: report
اللغة: English
العلاقة: http://www.lipidworld.com/content/12/1/175Test
الإتاحة: http://www.lipidworld.com/content/12/1/175Test
حقوق: Copyright 2013 Nagy et al.; licensee BioMed Central Ltd.
رقم الانضمام: edsbas.3773115E
قاعدة البيانات: BASE